Immune Design is a clinical stage immunotherapy company employing next-generation in vivo approaches to enable the body’s immune system to fight disease. The company’s technologies are engineered to activate the immune system’s natural ability to create tumor-specific cytotoxic T cells to fight cancer and other chronic diseases. Immune Design’s clinical programs are the product of its two synergistic discovery platforms: ZVexTM and GLAASTM.
Aug 9, 2016
Aug 2, 2016
Aug 9, 2016 at 1:30 PM PT
Jun 8, 2016 at 5:00 PM ET
(Please note: Webcast will begin at 5:30 p.m. ET)